Meehan DT - Search Results

1

Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.

Cosgrove D, Dufek B, Meehan DT, Delimont D, Hartnett M, Samuelson G, Gratton MA, Phillips G, MacKenna DA, Bain G. Cosgrove D, et al. Among authors: meehan dt. Kidney Int. 2018 Aug;94(2):303-314. doi: 10.1016/j.kint.2018.02.024. Epub 2018 May 16. Kidney Int. 2018. PMID: 29759420 Free PMC article.

2

Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.

Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC. Cosgrove D, et al. Among authors: meehan dt. Genes Dev. 1996 Dec 1;10(23):2981-92. doi: 10.1101/gad.10.23.2981. Genes Dev. 1996. PMID: 8956999 Free article.

3

Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome.

Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, Siegel M. Cosgrove D, et al. Among authors: meehan dt. Hear Res. 1998 Jul;121(1-2):84-98. doi: 10.1016/s0378-5955(98)00069-0. Hear Res. 1998. PMID: 9682811

4

Role for transforming growth factor-beta1 in alport renal disease progression.

Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D. Sayers R, et al. Among authors: meehan dt. Kidney Int. 1999 Nov;56(5):1662-73. doi: 10.1046/j.1523-1755.1999.00744.x. Kidney Int. 1999. PMID: 10571774 Free article.

5

Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

Cosgrove D, Rodgers K, Meehan D, Miller C, Bovard K, Gilroy A, Gardner H, Kotelianski V, Gotwals P, Amatucci A, Kalluri R. Cosgrove D, et al. Am J Pathol. 2000 Nov;157(5):1649-59. doi: 10.1016/s0002-9440(10)64802-x. Am J Pathol. 2000. PMID: 11073824 Free PMC article.

6

Strial marginal cells play a role in basement membrane homeostasis: in vitro and in vivo evidence.

Gratton MA, Meehan DT, Smyth BJ, Cosgrove D. Gratton MA, et al. Among authors: meehan dt. Hear Res. 2002 Jan;163(1-2):27-36. doi: 10.1016/s0378-5955(01)00358-6. Hear Res. 2002. PMID: 11788196

7

Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis.

Rodgers KD, Rao V, Meehan DT, Fager N, Gotwals P, Ryan ST, Koteliansky V, Nemori R, Cosgrove D. Rodgers KD, et al. Among authors: meehan dt. Kidney Int. 2003 Apr;63(4):1338-55. doi: 10.1046/j.1523-1755.2003.00871.x. Kidney Int. 2003. PMID: 12631350 Free article.

8

Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).

Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, Meehan DT, Rodgers K, Berridge BR, Bhattacharya G, Cosgrove D. Rao VH, et al. Among authors: meehan dt. Kidney Int. 2003 May;63(5):1736-48. doi: 10.1046/j.1523-1755.2003.00939.x. Kidney Int. 2003. PMID: 12675849 Free article.

9

Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome.

Rao VH, Lees GE, Kashtan CE, Delimont DC, Singh R, Meehan DT, Bhattacharya G, Berridge BR, Cosgrove D. Rao VH, et al. Among authors: meehan dt. Pediatr Nephrol. 2005 Jun;20(6):732-9. doi: 10.1007/s00467-004-1805-5. Epub 2005 Mar 22. Pediatr Nephrol. 2005. PMID: 15782307

10

Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology.

Gratton MA, Rao VH, Meehan DT, Askew C, Cosgrove D. Gratton MA, et al. Among authors: meehan dt. Am J Pathol. 2005 May;166(5):1465-74. doi: 10.1016/S0002-9440(10)62363-2. Am J Pathol. 2005. PMID: 15855646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page